Company news

Inovio Pharmaceuticals, Inc. news in 2022

Inovio Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.

View company

INOVIO Provides an Update on Lassa Fever and MERS Programs

November 16, 2022

INOVIO Reports Financial Results and Highlights for the Third Quarter 2022

November 7, 2022

INOVIO Provides Update on COVID-19 Heterologous Booster Vaccine Candidate, INO-4800

October 26, 2022

INOVIO to Report Third Quarter 2022 Financial Results on November 8, 2022

October 24, 2022

INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis

October 12, 2022

INOVIO Reports Financial Results and Highlights for the Second Quarter 2022

August 8, 2022

INOVIO to Report Second Quarter 2022 Financial Results on August 9, 2022

July 25, 2022

INOVIO Announces Corporate Reorganization to Reduce Operational Expenses and Focus on Opportunities to Bring the Promise of DNA Medicines to Patients

July 18, 2022

INOVIO Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

June 30, 2022

INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer

June 26, 2022

INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022

May 26, 2022

INOVIO Announces the Appointment of Jacqueline Shea, Ph.D., as Chief Executive Officer

May 9, 2022

INOVIO to Report First Quarter 2022 Financial Results on May 10, 2022

April 25, 2022

INOVIO Reports Fourth Quarter 2021 and Year-End Financial Results

February 28, 2022

INOVIO to Report Fourth Quarter and Year-End 2021 Financial Results on March 1, 2022

February 14, 2022

Calls in 2022